The consensus price target hints at a 47.8% upside potential for Clearfield (CLFD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings ...

The top read ophthalmology articles of 2025 focused on a variety of topics within the field, including links between ...

Pediatric patients aged 10 years and older with iron deficiency may now be treated with Accrufer following an expanded FDA approval.

In this article, Russ Koesterich discusses recent changes to stock/bond correlations and the impact that inflation, or a lack ...

Bitcoin may face a decline to $30,000 amid stable money supply and limited QE prospects. Click here to find out what this ...